glp 1 advertisement Serena Williams Is the Surprising New Face of Weight-Loss Drugs GLP-1 Series #6: Guess what?

The pharmaceutical industry expects significant market disruption once generic alternatives receive Health Canada approval, potentially in summer 2026

Through Preferred Partner Learning Programs, pharmacists and chemists gain advanced clinical knowledge, enhanced safety awareness, and confident counseling skills that empower better and improved patient care outcomes

We cant wait to help you get your health back on track!

Wang D, Luo P, Wang Y, Li W, Wang C, Sun D, Zhang R, Su T, Ma X, Zeng C, Wang H, Ren J, Cao F: Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism

Effects of L-theaninecaffeine combination on sustained attention and inhibitory control among children with ADHD: a proof-of-concept neuroimaging RCT